In our study, we discovered that AMPK activation induces H3K9 hyperacetylation and inhibits cervical cancer growth in vivo and in vitro; this mechanism may be facilitated by an AMPK-dependent mechanism mediated by mTOR signaling inhibition. Here, PRKAA1 is linked to cervical cancer.